Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$516.99
-$4.97 (-0.95%)
Sep 22, 2026, 11:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -57.94M | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M | -59.42M | -106.96M | -151.97M | -147.54M | -112.19M | -98.74M | -85.8M | -76.9M | -85.91M | -81.2M | -70.73M | -57.52M | -64.55M | -63.1M | -61.65M | -52.55M |
Depreciation & Amortization | 381K | 386K | 392K | 2.24M | 377K | 379K | 363K | 298K | 267K | 168K | 142K | 135K | 126K | 124K | 129K | 121K | 110K | 107K | 106K | 97K | 89K | 113K |
Stock-Based Compensation | 35.37M | 34.02M | n/a | 26.25M | 25.16M | 20.93M | 17.68M | 17.9M | 24.4M | 19.9M | 14.85M | 12.66M | 10.97M | 11.25M | 8.08M | 8.12M | 7.94M | 7.48M | 6.36M | 6.24M | 8.18M | 6.1M |
Other Working Capital | 10.45M | -34.38M | -84.49M | 197.01M | -1.54M | -7.13M | -12.57M | 10M | 12.53M | -9.97M | 5.02M | 1.34M | -6.57M | -7.28M | 13.6M | 6.3M | 16.62M | -1.38M | -926K | 1.85M | 9.83M | -471K |
Other Non-Cash Items | 72.62M | -1.58M | 27.19M | 2.45M | 1.37M | 492K | 540K | 22K | 472K | 655K | 753K | 674K | 554K | 433K | 306K | 313K | 178K | n/a | 30.65M | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30.65M | n/a | n/a | n/a |
Change in Working Capital | -27.1M | -105.87M | -102.47M | 163.1M | -31.68M | -37.46M | -63.65M | 21.76M | -8.12M | -22.34M | 16.51M | 351K | -1.16M | -18.98M | 18.87M | 13.57M | 5.14M | 21K | 10.04M | 11.21M | 6.5M | 2.91M |
Operating Cash Flow | 23.33M | -167.44M | -133.46M | 79.85M | -47.05M | -88.89M | -104.49M | -66.98M | -134.95M | -149.16M | -79.93M | -84.92M | -75.31M | -84.07M | -58.52M | -59.07M | -57.36M | -49.91M | -48.05M | -45.56M | -46.88M | -43.43M |
Capital Expenditures | -4.25M | -3.85M | 390K | -857K | n/a | n/a | -195K | -779K | -5.13M | -357K | -1.04M | -339K | -69K | -35K | -29K | -33K | -103K | -52K | -113K | -50K | -2K | -44K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.54K | n/a | n/a | -3K | -65.17K | -19.34K | n/a | 787K | n/a | n/a | n/a |
Purchase of Investments | -148.85M | -157.83M | -212.96M | -478.21M | -225.53M | -130.81M | -350.19M | -416.03M | -280.79M | -84.2M | -474.89M | -68.85M | -91.87M | -198.82M | -12.79M | -14.2M | -78.93M | -37.57M | -54.75M | -115.3M | -130.35M | -93.72M |
Sales Maturities Of Investments | 190.2M | 353.87M | 240.15M | 275.07M | 273.39M | 294.69M | 302.43M | 214.42M | 163.82M | 182.61M | 113.8M | 119.39M | 88.21M | 11.99M | 79.2M | 79.37M | 98.27M | 93.55M | 70.51M | 155.44M | 103.03M | 60.3M |
Other Investing Acitivies | -2.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5M | n/a | n/a | 50.54K | n/a | n/a | 3K | 65.17K | 19.34K | n/a | -787K | n/a | n/a | n/a |
Investing Cash Flow | 34.2M | 192.19M | 27.58M | -207M | 47.86M | 163.88M | -47.95M | -202.39M | -122.1M | 98.05M | -362.12M | 50.2M | -3.73M | -186.86M | 66.39M | 65.14M | 19.24M | 55.93M | 15.64M | 40.09M | -27.33M | -33.46M |
Debt Repayment | n/a | n/a | -983K | 218.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15M | 15M | 34.79M | n/a | n/a | 50M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 10.38M | n/a | n/a | n/a | 48.17M | 262.15M | 244.21M | 1.85M | 6.18M | n/a | 8.96M | n/a | -886K | n/a | 545K | 7K | n/a | 478K |
Financial Cash Flow | 3.11M | 2.33M | 8.96M | 236.65M | 1.74M | 8.64M | 19.77M | 7.46M | 134.12M | 573.71M | 479.92M | 19.58M | 42.93M | 52.69M | 264.34M | n/a | 49.11M | n/a | 19.5M | 21.1M | 63.54M | 67.09M |
Net Cash Flow | 60.69M | 28.41M | -96.91M | 109.5M | 2.55M | 83.63M | -132.67M | -261.91M | -122.92M | 522.6M | 37.86M | -15.14M | -36.11M | -218.24M | 272.21M | 6.07M | 10.99M | 6.01M | -12.91M | 15.63M | -10.67M | -9.8M |
Free Cash Flow | 19.08M | -171.28M | -133.07M | 78.99M | -47.05M | -88.89M | -104.68M | -67.76M | -140.08M | -149.51M | -80.97M | -85.26M | -75.38M | -84.1M | -58.54M | -59.1M | -57.46M | -49.97M | -48.16M | -45.61M | -46.88M | -43.47M |
Adj. Free Cash Flow | -16.3M | -205.3M | -133.07M | 52.74M | -72.21M | -109.82M | -122.36M | -85.66M | -164.48M | -169.42M | -95.82M | -97.92M | -86.35M | -95.35M | -66.63M | -67.22M | -65.41M | -57.44M | -54.52M | -51.85M | -55.06M | -49.57M |
Maintenance CapEx | -381K | -386K | 780K | n/a | n/a | n/a | n/a | n/a | -3.94M | -357K | -142K | -135K | -69K | -35K | -29K | -33K | -103K | -52K | -106K | -50K | -2K | -44K |
Growth CapEx | -3.87M | -3.46M | -390K | -857K | n/a | n/a | -195K | -779K | -1.19M | n/a | -894K | -204K | n/a | n/a | n/a | n/a | n/a | n/a | -7K | n/a | n/a | n/a |
Owner Earnings | 22.95M | -167.82M | -132.68M | 79.85M | -47.05M | -88.89M | -104.49M | -66.98M | -138.89M | -149.51M | -80.08M | -85.06M | -75.38M | -84.1M | -58.54M | -59.1M | -57.46M | -49.97M | -48.16M | -45.61M | -46.88M | -43.47M |
Add to Watchlist
Select watchlists to add or remove MDGL